 Kristi Anseth
Concepts (703)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrogels | 164 | 2025 | 632 | 28.760 |
Why?
| | Polyethylene Glycols | 122 | 2025 | 596 | 19.070 |
Why?
| | Biocompatible Materials | 84 | 2024 | 396 | 12.430 |
Why?
| | Extracellular Matrix | 60 | 2025 | 495 | 10.660 |
Why?
| | Tissue Engineering | 56 | 2023 | 392 | 8.040 |
Why?
| | Cell Culture Techniques | 34 | 2023 | 345 | 6.490 |
Why?
| | Myofibroblasts | 18 | 2025 | 119 | 6.390 |
Why?
| | Aortic Valve | 24 | 2025 | 345 | 5.570 |
Why?
| | Chondrocytes | 24 | 2021 | 203 | 5.220 |
Why?
| | Polymers | 47 | 2024 | 471 | 5.000 |
Why?
| | Elasticity | 19 | 2024 | 199 | 4.840 |
Why?
| | Heart Valves | 14 | 2019 | 41 | 4.730 |
Why?
| | Mechanotransduction, Cellular | 10 | 2024 | 110 | 4.460 |
Why?
| | Sulfhydryl Compounds | 19 | 2024 | 185 | 4.440 |
Why?
| | Calcinosis | 12 | 2025 | 230 | 4.370 |
Why?
| | Fibroblasts | 21 | 2025 | 935 | 4.340 |
Why?
| | Cells, Cultured | 79 | 2025 | 4001 | 4.230 |
Why?
| | Cross-Linking Reagents | 35 | 2025 | 205 | 3.990 |
Why?
| | Organoids | 8 | 2023 | 104 | 3.780 |
Why?
| | Aortic Valve Stenosis | 9 | 2025 | 215 | 3.480 |
Why?
| | Osteogenesis | 15 | 2020 | 175 | 3.390 |
Why?
| | Cell Differentiation | 34 | 2024 | 1900 | 3.370 |
Why?
| | Oligopeptides | 19 | 2024 | 256 | 3.310 |
Why?
| | Tissue Scaffolds | 18 | 2024 | 199 | 3.150 |
Why?
| | Hydrazones | 7 | 2024 | 26 | 3.140 |
Why?
| | Cell Survival | 37 | 2024 | 1077 | 2.950 |
Why?
| | Swine | 35 | 2022 | 742 | 2.880 |
Why?
| | Click Chemistry | 10 | 2021 | 48 | 2.850 |
Why?
| | Photochemistry | 34 | 2021 | 131 | 2.850 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 17 | 2016 | 74 | 2.760 |
Why?
| | Osteoblasts | 14 | 2025 | 123 | 2.740 |
Why?
| | Animals | 141 | 2025 | 34479 | 2.610 |
Why?
| | Biomimetic Materials | 11 | 2018 | 71 | 2.600 |
Why?
| | Light | 22 | 2020 | 354 | 2.350 |
Why?
| | Cellular Microenvironment | 7 | 2022 | 80 | 2.340 |
Why?
| | Photolysis | 10 | 2025 | 90 | 2.340 |
Why?
| | Peptides | 15 | 2015 | 908 | 2.180 |
Why?
| | Drug Delivery Systems | 15 | 2024 | 325 | 2.160 |
Why?
| | Cartilage | 13 | 2018 | 180 | 2.110 |
Why?
| | Materials Testing | 34 | 2019 | 346 | 2.090 |
Why?
| | Cell Adhesion | 22 | 2014 | 445 | 1.990 |
Why?
| | Cell Movement | 11 | 2024 | 936 | 1.940 |
Why?
| | Photochemical Processes | 13 | 2024 | 102 | 1.930 |
Why?
| | Transforming Growth Factor beta1 | 12 | 2020 | 154 | 1.870 |
Why?
| | Cell Communication | 10 | 2016 | 298 | 1.830 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2024 | 189 | 1.820 |
Why?
| | Acrylic Resins | 3 | 2025 | 44 | 1.790 |
Why?
| | Proteins | 7 | 2023 | 932 | 1.780 |
Why?
| | Matrix Metalloproteinases | 9 | 2017 | 89 | 1.730 |
Why?
| | Esters | 6 | 2025 | 74 | 1.720 |
Why?
| | Cartilage, Articular | 8 | 2021 | 296 | 1.690 |
Why?
| | Collagen | 14 | 2021 | 429 | 1.610 |
Why?
| | Actins | 16 | 2022 | 401 | 1.590 |
Why?
| | Intestines | 4 | 2023 | 344 | 1.570 |
Why?
| | Insulin-Secreting Cells | 7 | 2014 | 366 | 1.510 |
Why?
| | Microscopy | 2 | 2023 | 140 | 1.450 |
Why?
| | Myoblasts | 6 | 2024 | 80 | 1.400 |
Why?
| | Azides | 5 | 2022 | 46 | 1.370 |
Why?
| | Hyaluronic Acid | 6 | 2024 | 211 | 1.350 |
Why?
| | Fibrosis | 8 | 2025 | 512 | 1.350 |
Why?
| | Melanoma | 4 | 2021 | 752 | 1.340 |
Why?
| | Mice | 50 | 2024 | 16602 | 1.320 |
Why?
| | Paracrine Communication | 3 | 2020 | 60 | 1.280 |
Why?
| | Cells, Immobilized | 7 | 2018 | 21 | 1.240 |
Why?
| | Molecular Structure | 21 | 2018 | 464 | 1.230 |
Why?
| | Cadherins | 3 | 2022 | 186 | 1.190 |
Why?
| | Islets of Langerhans | 7 | 2010 | 790 | 1.190 |
Why?
| | Humans | 112 | 2025 | 128417 | 1.160 |
Why?
| | Signal Transduction | 15 | 2022 | 4826 | 1.150 |
Why?
| | Coated Materials, Biocompatible | 5 | 2011 | 56 | 1.150 |
Why?
| | Anhydrides | 8 | 2010 | 18 | 1.140 |
Why?
| | Extracellular Matrix Proteins | 4 | 2013 | 140 | 1.140 |
Why?
| | Polymerization | 7 | 2018 | 124 | 1.130 |
Why?
| | Phenotype | 12 | 2025 | 3044 | 1.130 |
Why?
| | Fibroblast Growth Factor 2 | 5 | 2008 | 85 | 1.130 |
Why?
| | Cell Line | 16 | 2025 | 2731 | 1.110 |
Why?
| | Viscosity | 5 | 2024 | 89 | 1.100 |
Why?
| | Cell Proliferation | 21 | 2025 | 2344 | 1.090 |
Why?
| | Elastic Modulus | 8 | 2017 | 123 | 1.080 |
Why?
| | Gels | 9 | 2008 | 83 | 1.080 |
Why?
| | Serum | 3 | 2022 | 57 | 1.080 |
Why?
| | Capsules | 7 | 2019 | 37 | 1.070 |
Why?
| | Adaptor Proteins, Signal Transducing | 6 | 2021 | 391 | 1.070 |
Why?
| | Indoles | 4 | 2017 | 371 | 1.070 |
Why?
| | Spheroids, Cellular | 3 | 2017 | 73 | 1.070 |
Why?
| | Integrins | 3 | 2024 | 92 | 1.040 |
Why?
| | Transforming Growth Factor beta | 6 | 2024 | 445 | 1.030 |
Why?
| | Gene Expression | 9 | 2022 | 1456 | 1.020 |
Why?
| | Sulfides | 4 | 2022 | 94 | 1.010 |
Why?
| | Islets of Langerhans Transplantation | 4 | 2010 | 60 | 0.990 |
Why?
| | Allyl Compounds | 3 | 2022 | 21 | 0.990 |
Why?
| | Acrylates | 11 | 2012 | 45 | 0.990 |
Why?
| | Sus scrofa | 6 | 2020 | 45 | 0.980 |
Why?
| | Triazoles | 2 | 2024 | 147 | 0.970 |
Why?
| | Heparin | 6 | 2010 | 240 | 0.950 |
Why?
| | Mechanical Phenomena | 3 | 2019 | 83 | 0.930 |
Why?
| | Staphylococcus epidermidis | 3 | 2010 | 75 | 0.910 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2024 | 29 | 0.910 |
Why?
| | Actomyosin | 1 | 2024 | 17 | 0.900 |
Why?
| | Vancomycin | 3 | 2010 | 72 | 0.900 |
Why?
| | Kinetics | 21 | 2020 | 1615 | 0.900 |
Why?
| | Rheology | 7 | 2024 | 90 | 0.890 |
Why?
| | Heart Valve Diseases | 3 | 2014 | 151 | 0.890 |
Why?
| | Bone Regeneration | 4 | 2020 | 23 | 0.880 |
Why?
| | Collagenases | 3 | 2015 | 23 | 0.870 |
Why?
| | Regenerative Medicine | 2 | 2017 | 46 | 0.860 |
Why?
| | Polyesters | 6 | 2009 | 72 | 0.850 |
Why?
| | Norbornanes | 3 | 2013 | 14 | 0.840 |
Why?
| | Bone Substitutes | 5 | 2019 | 25 | 0.840 |
Why?
| | Delayed-Action Preparations | 10 | 2018 | 170 | 0.830 |
Why?
| | Sulfonamides | 3 | 2017 | 499 | 0.810 |
Why?
| | Alkynes | 5 | 2022 | 54 | 0.790 |
Why?
| | Peptide Fragments | 4 | 2013 | 684 | 0.780 |
Why?
| | Rats | 26 | 2022 | 5165 | 0.780 |
Why?
| | Genes, X-Linked | 1 | 2022 | 17 | 0.770 |
Why?
| | Podosomes | 1 | 2021 | 3 | 0.770 |
Why?
| | X Chromosome Inactivation | 1 | 2022 | 22 | 0.770 |
Why?
| | Cattle | 19 | 2018 | 960 | 0.770 |
Why?
| | Osteoporosis, Postmenopausal | 1 | 2022 | 40 | 0.770 |
Why?
| | Fibronectins | 7 | 2012 | 120 | 0.760 |
Why?
| | Stress, Mechanical | 9 | 2021 | 463 | 0.740 |
Why?
| | Skull | 5 | 2012 | 128 | 0.740 |
Why?
| | Elastomers | 1 | 2021 | 25 | 0.740 |
Why?
| | NIH 3T3 Cells | 11 | 2020 | 141 | 0.730 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2021 | 1185 | 0.730 |
Why?
| | Coculture Techniques | 7 | 2024 | 226 | 0.720 |
Why?
| | Chondrogenesis | 4 | 2011 | 82 | 0.720 |
Why?
| | Intestinal Mucosa | 5 | 2023 | 575 | 0.720 |
Why?
| | Dexamethasone | 4 | 2013 | 338 | 0.720 |
Why?
| | Bone and Bones | 5 | 2019 | 299 | 0.700 |
Why?
| | Myocytes, Cardiac | 5 | 2020 | 492 | 0.700 |
Why?
| | Mechanoreceptors | 1 | 2020 | 14 | 0.700 |
Why?
| | Calcium Signaling | 2 | 2020 | 233 | 0.700 |
Why?
| | Inflammation Mediators | 2 | 2020 | 495 | 0.690 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2021 | 101 | 0.680 |
Why?
| | Models, Biological | 9 | 2024 | 1691 | 0.670 |
Why?
| | Fluorescent Dyes | 5 | 2015 | 311 | 0.670 |
Why?
| | Regeneration | 4 | 2016 | 174 | 0.670 |
Why?
| | Tumor Microenvironment | 4 | 2024 | 623 | 0.670 |
Why?
| | Drug Carriers | 7 | 2017 | 115 | 0.660 |
Why?
| | Phosphates | 3 | 2012 | 168 | 0.660 |
Why?
| | Models, Chemical | 8 | 2009 | 263 | 0.650 |
Why?
| | Anthracenes | 1 | 2019 | 31 | 0.640 |
Why?
| | Methacrylates | 6 | 2012 | 112 | 0.640 |
Why?
| | Osteoporosis | 1 | 2022 | 233 | 0.630 |
Why?
| | Proteoglycans | 3 | 2013 | 109 | 0.630 |
Why?
| | Azo Compounds | 2 | 2018 | 26 | 0.620 |
Why?
| | Biophysics | 1 | 2019 | 69 | 0.620 |
Why?
| | Cyclooctanes | 1 | 2018 | 5 | 0.620 |
Why?
| | Aza Compounds | 1 | 2018 | 12 | 0.620 |
Why?
| | Viscoelastic Substances | 2 | 2020 | 10 | 0.610 |
Why?
| | Surface Properties | 12 | 2012 | 393 | 0.610 |
Why?
| | Lactic Acid | 6 | 2016 | 293 | 0.600 |
Why?
| | Peptides, Cyclic | 2 | 2010 | 255 | 0.600 |
Why?
| | Pulmonary Alveoli | 3 | 2017 | 366 | 0.600 |
Why?
| | Precision Medicine | 2 | 2022 | 384 | 0.590 |
Why?
| | Transcriptome | 5 | 2022 | 881 | 0.580 |
Why?
| | Alkaline Phosphatase | 8 | 2016 | 142 | 0.580 |
Why?
| | Proto-Oncogene Proteins B-raf | 2 | 2021 | 214 | 0.580 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2019 | 117 | 0.570 |
Why?
| | Cell Line, Tumor | 11 | 2024 | 3184 | 0.560 |
Why?
| | Molecular Probes | 1 | 2017 | 37 | 0.560 |
Why?
| | Myocardium | 5 | 2024 | 965 | 0.550 |
Why?
| | Nanoparticles | 3 | 2018 | 368 | 0.550 |
Why?
| | Insulin | 9 | 2014 | 2315 | 0.540 |
Why?
| | Cycloaddition Reaction | 6 | 2024 | 27 | 0.540 |
Why?
| | Antigens | 3 | 2013 | 353 | 0.530 |
Why?
| | Biopolymers | 3 | 2022 | 32 | 0.530 |
Why?
| | Apoptosis | 10 | 2017 | 2435 | 0.530 |
Why?
| | DNA | 6 | 2006 | 1390 | 0.530 |
Why?
| | Macromolecular Substances | 3 | 2017 | 211 | 0.520 |
Why?
| | Lipase | 2 | 2007 | 64 | 0.520 |
Why?
| | Polyvinyl Alcohol | 5 | 2002 | 14 | 0.520 |
Why?
| | Cell Self Renewal | 1 | 2016 | 54 | 0.520 |
Why?
| | Amino Acid Sequence | 7 | 2015 | 2040 | 0.510 |
Why?
| | Gene Expression Regulation | 8 | 2022 | 2505 | 0.500 |
Why?
| | Microspheres | 2 | 2015 | 124 | 0.500 |
Why?
| | 3T3 Cells | 5 | 2012 | 151 | 0.500 |
Why?
| | Muscle, Smooth | 4 | 2009 | 145 | 0.500 |
Why?
| | Microarray Analysis | 1 | 2015 | 120 | 0.490 |
Why?
| | Bone Morphogenetic Protein 2 | 2 | 2012 | 62 | 0.480 |
Why?
| | Rats, Sprague-Dawley | 11 | 2022 | 2239 | 0.470 |
Why?
| | Niacinamide | 1 | 2015 | 73 | 0.460 |
Why?
| | Phenylurea Compounds | 1 | 2015 | 89 | 0.460 |
Why?
| | Solubility | 5 | 2020 | 229 | 0.460 |
Why?
| | Macrophages | 2 | 2020 | 1460 | 0.450 |
Why?
| | Immobilized Proteins | 1 | 2014 | 11 | 0.450 |
Why?
| | Immunohistochemistry | 7 | 2022 | 1664 | 0.450 |
Why?
| | Microscopy, Confocal | 4 | 2012 | 308 | 0.440 |
Why?
| | Factor XIIIa | 1 | 2013 | 5 | 0.440 |
Why?
| | Antibodies | 2 | 2006 | 391 | 0.440 |
Why?
| | Protein Kinase Inhibitors | 2 | 2021 | 872 | 0.440 |
Why?
| | Cell Engineering | 1 | 2013 | 9 | 0.440 |
Why?
| | Mammals | 3 | 2023 | 268 | 0.440 |
Why?
| | Biochemistry | 1 | 2014 | 38 | 0.430 |
Why?
| | Staphylococcal Infections | 2 | 2009 | 379 | 0.430 |
Why?
| | Prostheses and Implants | 5 | 2009 | 136 | 0.430 |
Why?
| | Serum Albumin, Bovine | 2 | 2018 | 61 | 0.430 |
Why?
| | Microfluidics | 3 | 2010 | 51 | 0.420 |
Why?
| | beta Catenin | 1 | 2015 | 219 | 0.420 |
Why?
| | Epithelial Cells | 4 | 2022 | 1032 | 0.420 |
Why?
| | Compressive Strength | 5 | 2021 | 70 | 0.410 |
Why?
| | Orthopedics | 4 | 2007 | 141 | 0.410 |
Why?
| | Stem Cells | 3 | 2022 | 578 | 0.400 |
Why?
| | Biomarkers | 5 | 2022 | 3880 | 0.400 |
Why?
| | Polystyrenes | 5 | 2014 | 37 | 0.400 |
Why?
| | Nanocapsules | 1 | 2012 | 10 | 0.400 |
Why?
| | Cytokines | 1 | 2020 | 1983 | 0.400 |
Why?
| | Leukocyte Elastase | 2 | 2009 | 74 | 0.390 |
Why?
| | Time Factors | 14 | 2011 | 6482 | 0.390 |
Why?
| | Microfluidic Analytical Techniques | 4 | 2018 | 73 | 0.390 |
Why?
| | Molecular Weight | 5 | 2014 | 331 | 0.390 |
Why?
| | Disease Progression | 3 | 2021 | 2602 | 0.380 |
Why?
| | Muscle Contraction | 3 | 2024 | 420 | 0.370 |
Why?
| | Cardiomegaly | 2 | 2024 | 168 | 0.370 |
Why?
| | Biomechanical Phenomena | 6 | 2017 | 778 | 0.370 |
Why?
| | Nerve Net | 1 | 2014 | 256 | 0.370 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 325 | 0.370 |
Why?
| | Embryonic Stem Cells | 2 | 2014 | 119 | 0.370 |
Why?
| | TRPV Cation Channels | 2 | 2022 | 32 | 0.360 |
Why?
| | Awards and Prizes | 1 | 2012 | 62 | 0.360 |
Why?
| | Endothelial Cells | 2 | 2014 | 698 | 0.360 |
Why?
| | Tensile Strength | 5 | 2025 | 94 | 0.360 |
Why?
| | MAP Kinase Signaling System | 3 | 2021 | 302 | 0.360 |
Why?
| | Gelatin | 2 | 2017 | 40 | 0.360 |
Why?
| | Printing, Three-Dimensional | 2 | 2022 | 86 | 0.360 |
Why?
| | Culture Media | 4 | 2014 | 164 | 0.360 |
Why?
| | Metalloporphyrins | 1 | 2011 | 101 | 0.360 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2012 | 940 | 0.350 |
Why?
| | Superoxides | 1 | 2011 | 196 | 0.350 |
Why?
| | Titanium | 2 | 2010 | 79 | 0.350 |
Why?
| | Collagen Type I | 4 | 2020 | 117 | 0.350 |
Why?
| | Organ Culture Techniques | 1 | 2010 | 142 | 0.350 |
Why?
| | Combinatorial Chemistry Techniques | 1 | 2010 | 15 | 0.340 |
Why?
| | Prosthesis-Related Infections | 2 | 2009 | 75 | 0.340 |
Why?
| | Fibrosarcoma | 1 | 2009 | 20 | 0.330 |
Why?
| | Phosphinic Acids | 1 | 2009 | 9 | 0.330 |
Why?
| | Anti-Bacterial Agents | 2 | 2010 | 1663 | 0.330 |
Why?
| | fas Receptor | 1 | 2010 | 95 | 0.330 |
Why?
| | Magnetic Resonance Spectroscopy | 7 | 2009 | 508 | 0.330 |
Why?
| | Heart Defects, Congenital | 2 | 2014 | 740 | 0.330 |
Why?
| | Equipment Design | 4 | 2017 | 518 | 0.330 |
Why?
| | Pravastatin | 1 | 2009 | 26 | 0.330 |
Why?
| | Phosphoproteins | 3 | 2017 | 327 | 0.320 |
Why?
| | Recombinant Proteins | 5 | 2012 | 1281 | 0.320 |
Why?
| | Parathyroid Hormone | 2 | 2020 | 106 | 0.320 |
Why?
| | Transcription Factors | 4 | 2021 | 1628 | 0.320 |
Why?
| | Cardiomyopathies | 1 | 2013 | 335 | 0.320 |
Why?
| | Plasmids | 4 | 2007 | 354 | 0.320 |
Why?
| | Chemokine CCL2 | 1 | 2009 | 118 | 0.320 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2819 | 0.320 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2009 | 50 | 0.320 |
Why?
| | Sex Characteristics | 3 | 2025 | 721 | 0.320 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 326 | 0.320 |
Why?
| | Heart Valve Prosthesis | 3 | 2005 | 111 | 0.310 |
Why?
| | Enzymes | 1 | 2009 | 64 | 0.310 |
Why?
| | Bioprinting | 2 | 2022 | 23 | 0.310 |
Why?
| | Trans-Activators | 3 | 2021 | 381 | 0.310 |
Why?
| | In Vitro Techniques | 5 | 2014 | 1039 | 0.300 |
Why?
| | Protein Engineering | 2 | 2008 | 105 | 0.300 |
Why?
| | Dendritic Cells | 1 | 2012 | 479 | 0.300 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2009 | 112 | 0.300 |
Why?
| | Polyhydroxyethyl Methacrylate | 3 | 2007 | 10 | 0.300 |
Why?
| | Cell Division | 5 | 2004 | 778 | 0.300 |
Why?
| | Hemodynamics | 1 | 2013 | 1081 | 0.300 |
Why?
| | Transfection | 5 | 2011 | 893 | 0.290 |
Why?
| | High-Throughput Screening Assays | 2 | 2025 | 134 | 0.290 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1923 | 0.290 |
Why?
| | Smad Proteins | 1 | 2008 | 37 | 0.290 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 480 | 0.290 |
Why?
| | Glucose Oxidase | 4 | 2011 | 26 | 0.290 |
Why?
| | Protein Binding | 6 | 2010 | 2103 | 0.290 |
Why?
| | Microscopy, Electron, Scanning | 7 | 2012 | 194 | 0.290 |
Why?
| | Glucocorticoids | 1 | 2012 | 571 | 0.290 |
Why?
| | Biofilms | 1 | 2010 | 241 | 0.290 |
Why?
| | Epigenesis, Genetic | 2 | 2024 | 615 | 0.290 |
Why?
| | Bone Cements | 2 | 2010 | 42 | 0.290 |
Why?
| | Glucose | 6 | 2014 | 982 | 0.280 |
Why?
| | Ultraviolet Rays | 5 | 2009 | 384 | 0.280 |
Why?
| | Temperature | 5 | 2013 | 625 | 0.280 |
Why?
| | Anoikis | 1 | 2007 | 32 | 0.270 |
Why?
| | Collagen Type II | 4 | 2009 | 47 | 0.270 |
Why?
| | Aorta | 1 | 2009 | 404 | 0.270 |
Why?
| | Shear Strength | 2 | 2020 | 67 | 0.270 |
Why?
| | Students | 1 | 2012 | 572 | 0.260 |
Why?
| | Growth Substances | 3 | 2003 | 150 | 0.260 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2006 | 51 | 0.260 |
Why?
| | Adsorption | 4 | 2012 | 138 | 0.260 |
Why?
| | Cell Shape | 3 | 2022 | 55 | 0.260 |
Why?
| | Nerve Tissue | 1 | 2005 | 7 | 0.250 |
Why?
| | Cell Nucleus | 2 | 2020 | 578 | 0.250 |
Why?
| | Biology | 2 | 2017 | 83 | 0.250 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 3 | 2014 | 39 | 0.250 |
Why?
| | Extracellular Fluid | 1 | 2005 | 31 | 0.250 |
Why?
| | Porosity | 2 | 2019 | 94 | 0.240 |
Why?
| | Biodegradation, Environmental | 6 | 2003 | 82 | 0.240 |
Why?
| | Staining and Labeling | 3 | 2015 | 137 | 0.240 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2005 | 14 | 0.240 |
Why?
| | Chromosomes, Human, Y | 1 | 2025 | 20 | 0.240 |
Why?
| | Carbonates | 1 | 2025 | 12 | 0.240 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2009 | 413 | 0.240 |
Why?
| | Bioprosthesis | 1 | 2005 | 39 | 0.240 |
Why?
| | Cell Separation | 2 | 2018 | 313 | 0.240 |
Why?
| | Calcium | 4 | 2024 | 1178 | 0.240 |
Why?
| | Microscopy, Atomic Force | 3 | 2017 | 115 | 0.240 |
Why?
| | PAX7 Transcription Factor | 1 | 2024 | 13 | 0.240 |
Why?
| | Carbamates | 1 | 2025 | 45 | 0.230 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 4 | 2010 | 815 | 0.230 |
Why?
| | Organophosphates | 1 | 2005 | 120 | 0.230 |
Why?
| | Polyanhydrides | 1 | 2004 | 2 | 0.230 |
Why?
| | Ultrasonography | 1 | 2008 | 710 | 0.230 |
Why?
| | MicroRNAs | 1 | 2011 | 677 | 0.230 |
Why?
| | Primary Cell Culture | 3 | 2016 | 158 | 0.230 |
Why?
| | Guided Tissue Regeneration | 1 | 2004 | 13 | 0.230 |
Why?
| | Cell Membrane | 3 | 2013 | 720 | 0.230 |
Why?
| | Vesiculovirus | 1 | 2024 | 16 | 0.230 |
Why?
| | Anisotropy | 1 | 2024 | 70 | 0.230 |
Why?
| | Diffusion | 4 | 2009 | 118 | 0.220 |
Why?
| | Boidae | 1 | 2024 | 20 | 0.220 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 4 | 2010 | 82 | 0.220 |
Why?
| | Cell Transplantation | 1 | 2003 | 35 | 0.220 |
Why?
| | Nitrites | 1 | 2004 | 81 | 0.220 |
Why?
| | Azacitidine | 1 | 2025 | 139 | 0.220 |
Why?
| | Chemistry, Pharmaceutical | 2 | 2017 | 100 | 0.210 |
Why?
| | Drug Design | 3 | 2012 | 154 | 0.210 |
Why?
| | Cell Cycle | 2 | 2019 | 581 | 0.210 |
Why?
| | Reproducibility of Results | 3 | 2020 | 3020 | 0.210 |
Why?
| | Microscopy, Fluorescence | 3 | 2012 | 399 | 0.210 |
Why?
| | Aldehydes | 2 | 2014 | 138 | 0.210 |
Why?
| | Endoglin | 2 | 2016 | 19 | 0.210 |
Why?
| | Male | 17 | 2025 | 62857 | 0.210 |
Why?
| | Annexin A2 | 1 | 2022 | 10 | 0.210 |
Why?
| | Butadienes | 1 | 2003 | 35 | 0.210 |
Why?
| | Laminin | 3 | 2008 | 68 | 0.200 |
Why?
| | Axons | 2 | 2014 | 188 | 0.200 |
Why?
| | Weight-Bearing | 1 | 2004 | 183 | 0.200 |
Why?
| | Calcification, Physiologic | 1 | 2002 | 34 | 0.200 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2012 | 1936 | 0.200 |
Why?
| | Neurons | 3 | 2010 | 1448 | 0.200 |
Why?
| | Hydrolysis | 5 | 2025 | 184 | 0.200 |
Why?
| | Mice, Inbred BALB C | 3 | 2010 | 1228 | 0.200 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 25 | 0.200 |
Why?
| | Particle Size | 4 | 2012 | 352 | 0.200 |
Why?
| | Receptors, Cell Surface | 3 | 2008 | 371 | 0.190 |
Why?
| | Interstitial Cells of Cajal | 2 | 2019 | 4 | 0.190 |
Why?
| | Morphogenesis | 1 | 2023 | 156 | 0.190 |
Why?
| | Gene Expression Profiling | 2 | 2022 | 1688 | 0.190 |
Why?
| | Robotics | 1 | 2023 | 90 | 0.190 |
Why?
| | Sex Factors | 3 | 2022 | 1945 | 0.190 |
Why?
| | Ovariectomy | 1 | 2022 | 136 | 0.190 |
Why?
| | Mice, Nude | 4 | 2015 | 682 | 0.190 |
Why?
| | Osteopontin | 3 | 2006 | 30 | 0.180 |
Why?
| | Organogenesis | 1 | 2022 | 56 | 0.180 |
Why?
| | Isoelectric Point | 1 | 2021 | 23 | 0.180 |
Why?
| | Drug Compounding | 4 | 2005 | 94 | 0.180 |
Why?
| | Base Sequence | 4 | 2012 | 2135 | 0.180 |
Why?
| | Vinculin | 2 | 2013 | 10 | 0.180 |
Why?
| | Temporomandibular Joint | 1 | 2001 | 8 | 0.180 |
Why?
| | Glycosaminoglycans | 4 | 2008 | 84 | 0.180 |
Why?
| | Focal Adhesions | 2 | 2015 | 44 | 0.180 |
Why?
| | Sialoglycoproteins | 3 | 2006 | 152 | 0.180 |
Why?
| | Membrane Proteins | 2 | 2020 | 1105 | 0.180 |
Why?
| | Isoproterenol | 1 | 2021 | 107 | 0.180 |
Why?
| | Muramidase | 2 | 2012 | 75 | 0.180 |
Why?
| | Secretory Pathway | 1 | 2020 | 6 | 0.180 |
Why?
| | THP-1 Cells | 1 | 2020 | 22 | 0.180 |
Why?
| | Tricarboxylic Acids | 1 | 2000 | 10 | 0.170 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2021 | 125 | 0.170 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2025 | 735 | 0.170 |
Why?
| | Chromatography, Gel | 3 | 2007 | 127 | 0.170 |
Why?
| | Bacterial Adhesion | 2 | 2012 | 91 | 0.170 |
Why?
| | Hydroxamic Acids | 1 | 2020 | 88 | 0.170 |
Why?
| | Wound Healing | 4 | 2022 | 305 | 0.170 |
Why?
| | Viral Proteins | 2 | 2024 | 321 | 0.170 |
Why?
| | Fluoresceins | 2 | 2012 | 47 | 0.170 |
Why?
| | DNA Methylation | 1 | 2025 | 604 | 0.170 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2017 | 112 | 0.170 |
Why?
| | Photosensitizing Agents | 1 | 2000 | 31 | 0.170 |
Why?
| | Hexanes | 1 | 1999 | 4 | 0.160 |
Why?
| | Dicarboxylic Acids | 1 | 1999 | 6 | 0.160 |
Why?
| | Acetylation | 1 | 2020 | 237 | 0.160 |
Why?
| | Adipogenesis | 2 | 2011 | 49 | 0.160 |
Why?
| | DNA Primers | 3 | 2012 | 510 | 0.160 |
Why?
| | Boronic Acids | 1 | 2019 | 37 | 0.160 |
Why?
| | Ligands | 2 | 2014 | 614 | 0.160 |
Why?
| | Bone Diseases | 1 | 2019 | 59 | 0.160 |
Why?
| | Antibodies, Immobilized | 1 | 2018 | 1 | 0.160 |
Why?
| | Isomerism | 2 | 2018 | 48 | 0.160 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2020 | 207 | 0.150 |
Why?
| | Histone Deacetylases | 1 | 2020 | 210 | 0.150 |
Why?
| | Receptors, Fibroblast Growth Factor | 2 | 2010 | 65 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2013 | 421 | 0.150 |
Why?
| | Bioengineering | 1 | 2018 | 19 | 0.150 |
Why?
| | Phenylacetates | 1 | 2018 | 9 | 0.150 |
Why?
| | Female | 13 | 2025 | 68153 | 0.150 |
Why?
| | DNA Ligases | 1 | 2018 | 7 | 0.150 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 82 | 0.150 |
Why?
| | Jurkat Cells | 2 | 2010 | 131 | 0.150 |
Why?
| | Gold | 1 | 2019 | 118 | 0.150 |
Why?
| | Bacteriophage T4 | 1 | 2018 | 15 | 0.150 |
Why?
| | Absorbable Implants | 2 | 2009 | 35 | 0.150 |
Why?
| | Equipment Failure Analysis | 2 | 2017 | 131 | 0.150 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2018 | 70 | 0.150 |
Why?
| | beta-Cyclodextrins | 1 | 2018 | 25 | 0.150 |
Why?
| | Chemotaxis | 2 | 2009 | 130 | 0.150 |
Why?
| | Dendrimers | 1 | 2017 | 13 | 0.140 |
Why?
| | Animals, Newborn | 3 | 2006 | 803 | 0.140 |
Why?
| | Absorption | 2 | 2009 | 57 | 0.140 |
Why?
| | A549 Cells | 1 | 2017 | 58 | 0.140 |
Why?
| | Heart Diseases | 1 | 2021 | 345 | 0.140 |
Why?
| | Periodicals as Topic | 2 | 2017 | 204 | 0.140 |
Why?
| | Substrate Specificity | 2 | 2009 | 365 | 0.140 |
Why?
| | Heart | 1 | 2021 | 635 | 0.140 |
Why?
| | Biomimetics | 1 | 2017 | 40 | 0.140 |
Why?
| | Nanotubes, Carbon | 1 | 2017 | 42 | 0.140 |
Why?
| | Biomedical Engineering | 4 | 2001 | 25 | 0.140 |
Why?
| | Enzyme Stability | 2 | 2018 | 67 | 0.140 |
Why?
| | Rubber | 1 | 1996 | 6 | 0.130 |
Why?
| | Culture Media, Serum-Free | 2 | 2007 | 49 | 0.130 |
Why?
| | Elastin | 2 | 2008 | 77 | 0.130 |
Why?
| | Membrane Glycoproteins | 2 | 2024 | 466 | 0.130 |
Why?
| | DNA, Neoplasm | 1 | 2017 | 159 | 0.130 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2017 | 195 | 0.130 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2008 | 536 | 0.130 |
Why?
| | Maleimides | 2 | 2013 | 21 | 0.130 |
Why?
| | Antigens, Neoplasm | 1 | 2018 | 309 | 0.130 |
Why?
| | Furans | 2 | 2013 | 22 | 0.130 |
Why?
| | Nanomedicine | 1 | 2016 | 31 | 0.120 |
Why?
| | Stromal Cells | 1 | 2015 | 105 | 0.120 |
Why?
| | Hot Temperature | 1 | 2018 | 358 | 0.120 |
Why?
| | Composite Resins | 1 | 1996 | 108 | 0.120 |
Why?
| | Structure-Activity Relationship | 2 | 2009 | 530 | 0.120 |
Why?
| | Models, Theoretical | 4 | 2007 | 542 | 0.120 |
Why?
| | Histones | 1 | 2020 | 586 | 0.120 |
Why?
| | Medicine | 1 | 2017 | 118 | 0.120 |
Why?
| | Disease Models, Animal | 2 | 2022 | 3937 | 0.120 |
Why?
| | Ethylene Glycols | 3 | 2000 | 15 | 0.110 |
Why?
| | Electrophoresis, Agar Gel | 2 | 2004 | 26 | 0.110 |
Why?
| | Computational Biology | 2 | 2022 | 598 | 0.110 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2017 | 431 | 0.110 |
Why?
| | Cell-Matrix Junctions | 1 | 2014 | 3 | 0.110 |
Why?
| | Cytostatic Agents | 1 | 2014 | 6 | 0.110 |
Why?
| | Streptavidin | 1 | 2014 | 14 | 0.110 |
Why?
| | Glass | 1 | 2014 | 43 | 0.110 |
Why?
| | Integrin beta1 | 1 | 2013 | 19 | 0.110 |
Why?
| | Acyltransferases | 1 | 2014 | 53 | 0.110 |
Why?
| | Benzaldehydes | 1 | 2013 | 10 | 0.110 |
Why?
| | Molecular Mimicry | 1 | 2013 | 37 | 0.110 |
Why?
| | Cyclization | 2 | 2011 | 16 | 0.110 |
Why?
| | Basal Metabolism | 1 | 2014 | 57 | 0.110 |
Why?
| | Stage-Specific Embryonic Antigens | 1 | 2013 | 2 | 0.110 |
Why?
| | CD146 Antigen | 1 | 2013 | 41 | 0.110 |
Why?
| | Benzoquinones | 1 | 2014 | 47 | 0.110 |
Why?
| | Biophysical Phenomena | 1 | 2013 | 64 | 0.110 |
Why?
| | Coloring Agents | 1 | 2013 | 76 | 0.110 |
Why?
| | Fluorescence Resonance Energy Transfer | 2 | 2019 | 177 | 0.110 |
Why?
| | Muscle Cells | 1 | 2013 | 39 | 0.110 |
Why?
| | Cryoultramicrotomy | 1 | 2013 | 2 | 0.110 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2013 | 56 | 0.110 |
Why?
| | Decanoic Acids | 2 | 2005 | 8 | 0.100 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2014 | 197 | 0.100 |
Why?
| | Gelatin Sponge, Absorbable | 1 | 2012 | 5 | 0.100 |
Why?
| | Sulfhydryl Reagents | 1 | 2012 | 12 | 0.100 |
Why?
| | Developmental Biology | 1 | 2012 | 23 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 324 | 0.100 |
Why?
| | Wnt Proteins | 1 | 2013 | 126 | 0.100 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2013 | 130 | 0.100 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2012 | 43 | 0.100 |
Why?
| | Ethers | 1 | 2012 | 16 | 0.100 |
Why?
| | Connective Tissue Growth Factor | 1 | 2012 | 24 | 0.100 |
Why?
| | Biofouling | 1 | 2012 | 9 | 0.100 |
Why?
| | Fracture Healing | 1 | 2012 | 77 | 0.100 |
Why?
| | Systems Biology | 1 | 2012 | 59 | 0.100 |
Why?
| | Free Radicals | 1 | 2012 | 103 | 0.100 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2017 | 749 | 0.100 |
Why?
| | Crystallization | 2 | 2009 | 137 | 0.100 |
Why?
| | Bone Transplantation | 1 | 2012 | 101 | 0.090 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2013 | 357 | 0.090 |
Why?
| | China | 1 | 2012 | 190 | 0.090 |
Why?
| | Receptor, EphA5 | 1 | 2011 | 1 | 0.090 |
Why?
| | Ephrin-A5 | 1 | 2011 | 1 | 0.090 |
Why?
| | Thermodynamics | 1 | 2013 | 405 | 0.090 |
Why?
| | Endoplasmic Reticulum | 1 | 2013 | 260 | 0.090 |
Why?
| | Blotting, Western | 1 | 2013 | 1164 | 0.090 |
Why?
| | Half-Life | 1 | 2011 | 143 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2012 | 371 | 0.090 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2011 | 40 | 0.090 |
Why?
| | Biological Availability | 1 | 2011 | 122 | 0.090 |
Why?
| | Homeostasis | 1 | 2014 | 603 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2013 | 1269 | 0.090 |
Why?
| | Surface Plasmon Resonance | 1 | 2011 | 88 | 0.090 |
Why?
| | Ascorbic Acid | 1 | 2011 | 120 | 0.090 |
Why?
| | Heparin Lyase | 1 | 2010 | 4 | 0.090 |
Why?
| | Cell Physiological Phenomena | 1 | 2010 | 20 | 0.090 |
Why?
| | Carbohydrate Sequence | 1 | 2010 | 24 | 0.090 |
Why?
| | Polymethyl Methacrylate | 1 | 2010 | 21 | 0.090 |
Why?
| | Flow Cytometry | 2 | 2011 | 1142 | 0.090 |
Why?
| | Copper | 1 | 2011 | 107 | 0.090 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 586 | 0.080 |
Why?
| | Foreskin | 1 | 2009 | 5 | 0.080 |
Why?
| | Interleukin-10 | 1 | 2012 | 299 | 0.080 |
Why?
| | Proto-Oncogene Proteins | 1 | 2013 | 634 | 0.080 |
Why?
| | Polymethacrylic Acids | 2 | 2003 | 62 | 0.080 |
Why?
| | Enzyme Assays | 1 | 2009 | 25 | 0.080 |
Why?
| | Decorin | 1 | 2009 | 6 | 0.080 |
Why?
| | Lithium | 1 | 2009 | 37 | 0.080 |
Why?
| | Biochemical Phenomena | 1 | 2009 | 10 | 0.080 |
Why?
| | Biosensing Techniques | 1 | 2011 | 114 | 0.080 |
Why?
| | Adrenal Glands | 1 | 2009 | 70 | 0.080 |
Why?
| | Acrylamides | 1 | 2009 | 58 | 0.080 |
Why?
| | Cloning, Molecular | 1 | 2010 | 522 | 0.080 |
Why?
| | Bone Morphogenetic Proteins | 2 | 2007 | 129 | 0.080 |
Why?
| | Biotechnology | 1 | 2009 | 40 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 1999 | 0.080 |
Why?
| | Keratinocytes | 1 | 2010 | 243 | 0.080 |
Why?
| | Fibroblast Growth Factors | 1 | 2010 | 170 | 0.080 |
Why?
| | Amino Acid Motifs | 1 | 2009 | 209 | 0.080 |
Why?
| | Computer Simulation | 2 | 2013 | 939 | 0.080 |
Why?
| | Culture Techniques | 1 | 2008 | 80 | 0.080 |
Why?
| | Cysteine | 1 | 2010 | 186 | 0.080 |
Why?
| | X-Ray Diffraction | 2 | 2005 | 94 | 0.080 |
Why?
| | Serum Albumin | 1 | 2009 | 145 | 0.080 |
Why?
| | Microchemistry | 1 | 2008 | 17 | 0.080 |
Why?
| | Probability | 1 | 2009 | 305 | 0.080 |
Why?
| | Ultrasonics | 1 | 2008 | 47 | 0.080 |
Why?
| | Integrin alpha5beta1 | 1 | 2008 | 10 | 0.070 |
Why?
| | Matrix Metalloproteinase 13 | 1 | 2008 | 23 | 0.070 |
Why?
| | Recombinant Fusion Proteins | 1 | 2011 | 634 | 0.070 |
Why?
| | Integrin alphaVbeta3 | 1 | 2008 | 19 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2464 | 0.070 |
Why?
| | Surface-Active Agents | 1 | 2008 | 82 | 0.070 |
Why?
| | Fibrin | 1 | 2008 | 68 | 0.070 |
Why?
| | Microbial Sensitivity Tests | 1 | 2009 | 332 | 0.070 |
Why?
| | Mice, Inbred C57BL | 2 | 2010 | 5272 | 0.070 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1098 | 0.070 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 680 | 0.070 |
Why?
| | Lasers | 1 | 2008 | 132 | 0.070 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2009 | 3624 | 0.070 |
Why?
| | Drug Stability | 2 | 2005 | 144 | 0.070 |
Why?
| | Aggrecans | 1 | 2007 | 14 | 0.070 |
Why?
| | Surgical Wound Infection | 1 | 2010 | 277 | 0.070 |
Why?
| | Heparan Sulfate Proteoglycans | 1 | 2007 | 21 | 0.070 |
Why?
| | Mitogens | 1 | 2007 | 58 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 571 | 0.070 |
Why?
| | Hepatocyte Growth Factor | 1 | 2007 | 33 | 0.070 |
Why?
| | Calorimetry, Differential Scanning | 3 | 2005 | 36 | 0.070 |
Why?
| | Bioreactors | 1 | 2006 | 43 | 0.070 |
Why?
| | Antigen-Antibody Reactions | 1 | 2006 | 51 | 0.070 |
Why?
| | Environment | 1 | 2008 | 342 | 0.070 |
Why?
| | Water | 1 | 2009 | 440 | 0.060 |
Why?
| | Griseofulvin | 1 | 2005 | 2 | 0.060 |
Why?
| | Stem Cell Transplantation | 1 | 2007 | 165 | 0.060 |
Why?
| | Tetrazolium Salts | 1 | 2005 | 17 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2328 | 0.060 |
Why?
| | Nanotechnology | 1 | 2007 | 119 | 0.060 |
Why?
| | Sensitivity and Specificity | 2 | 2011 | 1815 | 0.060 |
Why?
| | Calcium Phosphates | 1 | 2005 | 22 | 0.060 |
Why?
| | Polymerase Chain Reaction | 1 | 2008 | 1020 | 0.060 |
Why?
| | Antineoplastic Agents | 1 | 2017 | 2051 | 0.060 |
Why?
| | X-Ray Microtomography | 2 | 2019 | 84 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2007 | 312 | 0.060 |
Why?
| | Antigens, CD | 1 | 2008 | 482 | 0.060 |
Why?
| | Ear, External | 1 | 2005 | 23 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 799 | 0.060 |
Why?
| | Thiazoles | 1 | 2005 | 115 | 0.060 |
Why?
| | Facial Bones | 1 | 2005 | 28 | 0.060 |
Why?
| | Glucagon | 1 | 2005 | 105 | 0.060 |
Why?
| | Nasal Septum | 1 | 2005 | 24 | 0.060 |
Why?
| | Immunoblotting | 1 | 2005 | 300 | 0.060 |
Why?
| | Cell Count | 1 | 2005 | 313 | 0.060 |
Why?
| | Nose | 1 | 2005 | 64 | 0.060 |
Why?
| | Larynx | 1 | 2005 | 55 | 0.060 |
Why?
| | Stress Fibers | 1 | 2004 | 18 | 0.060 |
Why?
| | Hexuronic Acids | 1 | 2004 | 23 | 0.060 |
Why?
| | Glucuronic Acid | 1 | 2004 | 25 | 0.060 |
Why?
| | MCF-7 Cells | 1 | 2024 | 115 | 0.060 |
Why?
| | Methylation | 1 | 2025 | 227 | 0.060 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2005 | 173 | 0.060 |
Why?
| | Sheep | 1 | 2007 | 828 | 0.060 |
Why?
| | Myofibrils | 1 | 2024 | 49 | 0.060 |
Why?
| | Cytoskeleton | 1 | 2005 | 180 | 0.060 |
Why?
| | Alginates | 1 | 2004 | 46 | 0.060 |
Why?
| | Photography | 1 | 2004 | 97 | 0.060 |
Why?
| | Cell Size | 1 | 2004 | 87 | 0.060 |
Why?
| | Postprandial Period | 1 | 2024 | 103 | 0.050 |
Why?
| | Immunity, Innate | 1 | 2009 | 802 | 0.050 |
Why?
| | Catalysis | 2 | 2017 | 305 | 0.050 |
Why?
| | Viral Envelope Proteins | 1 | 2024 | 80 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1628 | 0.050 |
Why?
| | Surgical Flaps | 1 | 2005 | 137 | 0.050 |
Why?
| | Trachea | 1 | 2005 | 221 | 0.050 |
Why?
| | Magnetic Phenomena | 1 | 2023 | 10 | 0.050 |
Why?
| | Gene Transfer Techniques | 1 | 2004 | 162 | 0.050 |
Why?
| | Cystatin C | 1 | 2022 | 65 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 999 | 0.050 |
Why?
| | Oxidation-Reduction | 3 | 2011 | 1001 | 0.050 |
Why?
| | Somatomedins | 1 | 2002 | 28 | 0.050 |
Why?
| | Polyvinyls | 1 | 2002 | 19 | 0.050 |
Why?
| | Biomarkers, Pharmacological | 1 | 2022 | 26 | 0.050 |
Why?
| | Glycoproteins | 1 | 2024 | 337 | 0.050 |
Why?
| | Injections | 1 | 2002 | 172 | 0.050 |
Why?
| | Extracellular Vesicles | 1 | 2024 | 129 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2023 | 173 | 0.050 |
Why?
| | Technology, Pharmaceutical | 1 | 2002 | 18 | 0.050 |
Why?
| | Subcutaneous Tissue | 1 | 2002 | 22 | 0.050 |
Why?
| | Paneth Cells | 1 | 2022 | 16 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2022 | 68 | 0.050 |
Why?
| | Genetic Therapy | 1 | 2003 | 290 | 0.050 |
Why?
| | Infant, Newborn | 2 | 2010 | 5687 | 0.050 |
Why?
| | HEK293 Cells | 1 | 2024 | 683 | 0.050 |
Why?
| | Cicatrix | 1 | 2022 | 58 | 0.050 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2001 | 80 | 0.050 |
Why?
| | Receptors, Notch | 1 | 2022 | 83 | 0.050 |
Why?
| | Temporomandibular Joint Disorders | 1 | 2001 | 8 | 0.050 |
Why?
| | Chlorobenzenes | 1 | 2001 | 9 | 0.050 |
Why?
| | Succinimides | 1 | 2001 | 16 | 0.050 |
Why?
| | Femur | 2 | 2019 | 245 | 0.050 |
Why?
| | Polyglycolic Acid | 1 | 2001 | 41 | 0.040 |
Why?
| | Chromosomes | 1 | 2021 | 101 | 0.040 |
Why?
| | Nucleic Acid Conformation | 1 | 2004 | 706 | 0.040 |
Why?
| | Lung | 1 | 2013 | 3743 | 0.040 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 514 | 0.040 |
Why?
| | Adrenergic beta-Agonists | 1 | 2021 | 129 | 0.040 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2000 | 136 | 0.040 |
Why?
| | Mathematical Computing | 1 | 2000 | 11 | 0.040 |
Why?
| | Gonadal Steroid Hormones | 1 | 2021 | 129 | 0.040 |
Why?
| | Ursidae | 1 | 2019 | 6 | 0.040 |
Why?
| | Fumarates | 1 | 2019 | 9 | 0.040 |
Why?
| | Polypropylenes | 1 | 2019 | 13 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2000 | 132 | 0.040 |
Why?
| | Lipids | 1 | 2003 | 620 | 0.040 |
Why?
| | Muscles | 1 | 2001 | 322 | 0.040 |
Why?
| | Blood Proteins | 1 | 2001 | 239 | 0.040 |
Why?
| | Antibodies, Monoclonal | 1 | 2006 | 1355 | 0.040 |
Why?
| | Mitochondria | 1 | 2005 | 848 | 0.040 |
Why?
| | Models, Genetic | 1 | 2022 | 591 | 0.040 |
Why?
| | Spectrophotometry, Infrared | 1 | 1999 | 53 | 0.040 |
Why?
| | Intracellular Space | 1 | 2019 | 70 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2024 | 831 | 0.040 |
Why?
| | Inflammation | 1 | 2009 | 2654 | 0.040 |
Why?
| | Zebrafish | 1 | 2023 | 464 | 0.040 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 2018 | 36 | 0.040 |
Why?
| | Drug Liberation | 1 | 2018 | 29 | 0.040 |
Why?
| | Prosthesis Implantation | 1 | 1999 | 144 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 420 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2004 | 2675 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 930 | 0.030 |
Why?
| | Quality Control | 1 | 1996 | 156 | 0.030 |
Why?
| | Ketanserin | 1 | 1996 | 12 | 0.030 |
Why?
| | Proteomics | 1 | 2022 | 1009 | 0.030 |
Why?
| | Genotype | 1 | 2021 | 1828 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2019 | 577 | 0.030 |
Why?
| | Sclerosis | 1 | 2014 | 12 | 0.030 |
Why?
| | Collagen Type III | 1 | 2014 | 14 | 0.030 |
Why?
| | Receptors, Wnt | 1 | 2013 | 2 | 0.030 |
Why?
| | Coatomer Protein | 1 | 2013 | 3 | 0.030 |
Why?
| | ras GTPase-Activating Proteins | 1 | 2013 | 15 | 0.030 |
Why?
| | Wnt-5a Protein | 1 | 2013 | 21 | 0.030 |
Why?
| | Exocytosis | 1 | 2014 | 86 | 0.030 |
Why?
| | Myosins | 1 | 2013 | 133 | 0.030 |
Why?
| | Cell Polarity | 1 | 2013 | 140 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2016 | 860 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2013 | 147 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 1996 | 440 | 0.020 |
Why?
| | Myocardial Infarction | 1 | 2019 | 1015 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 184 | 0.020 |
Why?
| | Algorithms | 1 | 1999 | 1618 | 0.020 |
Why?
| | Ear Cartilage | 1 | 2010 | 3 | 0.020 |
Why?
| | Pilot Projects | 1 | 2016 | 1563 | 0.020 |
Why?
| | Microtubules | 1 | 2013 | 259 | 0.020 |
Why?
| | Skin | 2 | 2010 | 718 | 0.020 |
Why?
| | Integrin beta4 | 1 | 2010 | 1 | 0.020 |
Why?
| | Keratin-14 | 1 | 2010 | 14 | 0.020 |
Why?
| | Enzymes, Immobilized | 1 | 2011 | 29 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 635 | 0.020 |
Why?
| | Dermis | 1 | 2010 | 31 | 0.020 |
Why?
| | Pseudomonas aeruginosa | 1 | 2012 | 336 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2010 | 313 | 0.020 |
Why?
| | Physical Phenomena | 1 | 2009 | 13 | 0.020 |
Why?
| | Amino Acids | 1 | 2013 | 474 | 0.020 |
Why?
| | Dimerization | 2 | 1999 | 188 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 334 | 0.020 |
Why?
| | Escherichia coli | 1 | 2012 | 765 | 0.020 |
Why?
| | Buffers | 1 | 2007 | 55 | 0.020 |
Why?
| | Rats, Inbred Lew | 1 | 2007 | 92 | 0.020 |
Why?
| | Nanocomposites | 1 | 2007 | 14 | 0.020 |
Why?
| | Skull Fractures | 1 | 2007 | 33 | 0.020 |
Why?
| | Protons | 1 | 2007 | 80 | 0.020 |
Why?
| | Chromatography, Supercritical Fluid | 1 | 2005 | 3 | 0.020 |
Why?
| | Chemical Precipitation | 1 | 2005 | 37 | 0.020 |
Why?
| | Powders | 1 | 2005 | 43 | 0.020 |
Why?
| | Excipients | 1 | 2005 | 51 | 0.020 |
Why?
| | Green Fluorescent Proteins | 1 | 2007 | 380 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2019 | 10151 | 0.020 |
Why?
| | Solutions | 1 | 2004 | 147 | 0.010 |
Why?
| | Models, Statistical | 1 | 2006 | 621 | 0.010 |
Why?
| | DNA Replication | 1 | 2004 | 225 | 0.010 |
Why?
| | Patella | 1 | 2000 | 22 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2004 | 1198 | 0.010 |
Why?
| | Injections, Subcutaneous | 1 | 1999 | 144 | 0.010 |
Why?
| | Adhesiveness | 1 | 1996 | 19 | 0.010 |
Why?
| | Freezing | 1 | 1996 | 86 | 0.010 |
Why?
| | Mucins | 1 | 1996 | 70 | 0.010 |
Why?
|
|
Anseth's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|